Back to top
more

Medtronic (MDT)

(Delayed Data from NYSE)

$81.04 USD

81.04
3,687,915

-0.62 (-0.76%)

Updated Jun 14, 2024 04:00 PM ET

After-Market: $81.04 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (139 out of 250)

Industry: Medical - Products

Better trading starts here.

Brokerage Reports

Research for MDT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Medtronic PLC [MDT]

Reports for Purchase

Showing records 301 - 320 ( 504 total )

Company: Medtronic PLC

Industry: Medical - Products

Record: 301

08/26/2016

Company Report

Pages: 9

Not The Best Nor The Worst of MDT''s Quarters; Maintain NEUTRAL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 302

08/26/2016

Company Report

Pages: 9

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 303

08/16/2016

Company Report

Pages: 9

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 304

08/09/2016

Company Report

Pages: 9

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 305

08/01/2016

Company Report

Pages: 10

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 306

07/15/2016

Daily Note

Pages: 41

Medical Devices: 2Q16 MedTech Preview: Stable Trends and Healthy Underlying Fundamentals

Provider: WEDBUSH SECURITIES INC.

Price: 100.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 307

07/11/2016

Industry Report

Pages: 2

Industry Report ; MEDTECH; This report contains brief updates on the following: MDT, JNJ, EW. These companies are covered in more detail in separate Daily Notes and/or Company Reports.

Provider: ZACKS INVESTMENT RESEARCH

Price: 10.00

Company: Medtronic PLC

Industry: Medical - Products

Record: 308

07/10/2016

Industry Report

Pages: 6

Diabetes: Artificial Pancreas Workshop Provides Insights On the Future of the Diabetes Market

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 309

06/28/2016

Company Report

Pages: 10

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 310

06/07/2016

Company Report

Pages: 15

Innovation and Globalization Highlights From Analyst Meeting; Maintain NEUTRAL

Provider: WEDBUSH SECURITIES INC.

Price: 50.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 311

06/05/2016

Industry Report

Pages: 5

Diabetes Technology Update: Regulatory Environment for AP Programs Less Onerous; MDT''s 670G and CGM Technology Improve; DXCM Seeks Replacement Claim

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 312

06/02/2016

Company Report

Pages: 10

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 313

06/01/2016

Company Report

Pages: 8

FY4Q16 Review: Adjustments Obscure Operating/EPS Leverage Potential; Maintain Neutral; PT to $82

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 314

05/27/2016

Company Report

Pages: 9

FY4Q16 Preview: Expecting an In Line Quarter Followed By Tougher Comps Ahead; Maintain Neutral

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 315

05/27/2016

Company Report

Pages: 9

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 316

05/19/2016

Industry Report

Pages: 5

J-J Medical Devices Investor Day Takeaways on Robotic Surgery, Diabetes, AFib,Sinus Surgery, Endoscopic Stapling

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 317

05/16/2016

Industry Report

Pages: 7

MDT/UHC Insulin Pump Agreement Could Become A Significant POSITIVE for the Other

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 318

05/03/2016

Daily Note

Pages: 9

Volatility in Diabetes Stocks Following UNH/MDT Agreement Creates Buying Opportunity; Reiterate OUTPERFORM on DXCM, PODD, TNDM

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: Medtronic PLC

Industry: Medical - Products

Record: 319

05/03/2016

Company Report

Pages: 9

Price: 24.95

Company: Medtronic PLC

Industry: Medical - Products

Record: 320

04/26/2016

Daily Note

Pages: 15

Diabetes 1Q16 Earnings Preview: Despite Seasonally Soft 1Q, Expecting Healthy Trends Driven By New Product Launches

Provider: WEDBUSH SECURITIES INC.

Price: 50.00

Research Provided by a Third Party